期刊文献+

诺舒阻抗控制子宫内膜切除系统治疗功血的满意度及其影响因素分析 被引量:1

Endometrial resection shu impedance control system treatment work satisfaction and its influencing factors analysis of blood
下载PDF
导出
摘要 目的分析诺舒阻抗控制子宫内膜切除系统治疗功血患者的满意度及其相关影响因素。方法选取2012年9月~2015年7月在我院行诺舒阻抗控制子宫内膜切除系统治疗的功血患者81例为研究对象,由妇科医生进行电话问卷调查,并分析其影响因素。结果治疗后,患者满意度为97%,不满意度为3%。影响满意度的因素有诺舒治疗后阴道点滴出血、阴道排液、痛经缓解情况及医生服务态度等。结论诺舒阻抗控制子宫内膜切除系统治疗功血患者满意度较好,尤其诺舒治疗后闭经、阴道流液时间短,痛经缓解明显,医生服务态度好,患者满意度较高,值得临床推广。
出处 《实用妇科内分泌电子杂志》 2015年第11期124-125,共2页 Electronic Journal of Practical Gynecological Endocrinology
  • 相关文献

参考文献6

二级参考文献43

  • 1夏恩兰.第二代子宫内膜去除术[J].中华妇产科杂志,2004,39(12):846-847. 被引量:16
  • 2丰有吉,沈铿主编.妇产科学[M].2版.北京:人民卫生出版社,2011:214.215.
  • 3Davidson BR, Dipiero CM, Govoni KD, et al. Abnormal uterine bleeding during the reproductive years. J Midwifery Womens Health,2012, 57:248-254.
  • 4Pollock W, Jamieson W. Next-generation NovaSure device for endometrial ablation:assessing ease-of-use among physicians. Int J Womens Health ,2012,4 : 109-113.
  • 5Bongers MY. Second-generation endometrial ablation treatment: Novasure. Best Pract Res Clin Obstet Gynaecol, 2007, 21: 989- 994.
  • 6Kleijn JH, Engels R, Bourdrez P, et al. Five-year follow up of a randomised controlled trial comparing NovaSure and ThermaChoice endometrial ablation. BJOG,2008,115 : 193-198.
  • 7Fakih M, Cherfan V, Abdallah E. Success rate, quality of life, and descriptive analysis after generalized endometrial ablation in an obese population. Int J Gynaecol Obstet,2011,113 : 120-123.
  • 8Asgari Z, Moini A, Samiee H, et al. Endometrial ablation with the NovaSure system in Iran. Int .1 Gvnaecol Obstet.2011 _ 114,73-75.
  • 9谢幸.妇产科学[M].北京:人民卫生出版社,2013:274.
  • 10Lglesias DA,Madani SS,Davis JD. The e{fectiveness of endometrial ablation with the Hydro Thermablator (HTA)for abnormal uterine bleeding[J]. Am J Obstet Gynecol,2010,202(6) :622.

共引文献45

同被引文献13

  • 1邓姗,郎景和.左炔诺孕酮宫内缓释系统的临床功用及相关基础研究[J].国外医学(妇产科学分册),2004,31(5):285-288. 被引量:148
  • 2谢辛,苟文丽主编.妇产科学[M].第8版.北京:人民卫生出版社,2013:326-328.
  • 3Pollock W,Jamieson W. Next-generation NovaSure device for endometrial ablation:assessing ease-of-use among physicians [J].Int J Womens Health,2012,4 : 109 - 113.
  • 4Higham JM. O'Brien PM, Shaw RW. Assessment of menstru- al blood loss using a pictorial chart[ J]. Br J Obstet Gynae- co1,1990,97(8) :734 -739.
  • 5Laberge PY. NovaSureTM : the bipolar radiofrequency endom- etrial ablation system for dysfunctional uterine bleeding[ J]. Womens Health ( Lond Engl), 2006,2 ( 5 ) : 687 - 693.
  • 6Campbell P, Monaghan C, Parker M. NovaSure endometrial ablation:a review of 400 eases [ J]. Gynecol Surg, 2012,9 ( 1 ) :73 - 76.
  • 7Lukes AS, Mcbride RJ, Herring AH, et al. Improved premen- strual syndrome symptoms after NovaSure endometrial ablation [J]. J Minim Invasive Gynecol,2011,18(5) :607 -611.
  • 8Fulop T, R6k6czi I, Barna I. NovaSure impedance controlled endometrial ablation :long-term follow-up results [ J ]. J Min- im Invasive Gynecol,2007,14 ( 1 ) :85 - 90.
  • 9Baldaszti E, Wimmer-Puchinger B, L~schke K. Acceptability of the long-term contraceptive levonorgestrel-reieasing intra- uterine system(Mirena) :a 3-year follow-up study[J].Con- traception,2003,67 (2) : 87 - 91.
  • 10Hazard Report. Hazard report. Incorrect measurement of u- terine cavity while using Hologic NovaSure endometrial abla- tion system can result in patient injury[ J]. Health Devices, 2009,38 (9) : 302 - 304.

引证文献1

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部